Phase II study of first line treatment of Chronic Graft versus Host Disease with Arsenic Trioxide

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2016
This article has no abstract
Epistemonikos ID: b110c082390cee5c0d2e959a773cbed1471ada59
First added on: Jan 23, 2025